Seong Yong Park

Medicine and Dentistry

1. Esophagectomy 100%
2. Non Small Cell Lung Cancer 84%
3. Esophageal Squamous Cell Carcinoma 70%
4. Overall Survival 60%
5. Lung Cancer 57%
6. Esophageal Cancer 52%
7. Retroperitoneal Lymph Node Dissection 43%
8. Recurrent Disease 42%
9. Lobectomy 36%
10. Neoplasm 30%
11. Chemoradiotherapy 27%
12. Pneumonectomy 25%
13. Hazard Ratio 25%
14. Lung Adenocarcinoma 22%
15. Lymph Node Metastasis 21%
16. Disease Free Survival 21%
17. Malignant Neoplasm 20%
18. Prognostic Factor 20%
19. Computer Assisted Tomography 16%
20. Lung 16%
21. Surgery 16%
22. Neoadjuvant Therapy 16%
23. Recurrent Laryngeal Nerve 15%
24. Lymph Node 15%
25. Fluorodeoxyglucose F 18 14%
26. Thymus Cancer 14%
27. Survival Rate 13%
28. Multivariate Analysis 13%
29. Median Follow Up 13%
30. Diseases 13%
31. Adjuvant Chemotherapy 13%
32. Chemoradiation Therapy 12%
33. Odds Ratio 12%
34. Adenocarcinoma 12%
35. Mediastinal Lymph Node 12%
36. Glycolysis 11%
37. positron emission tomographic scan 11%
38. Radiation Therapy 11%
39. Surgeon 11%
40. Recurrence Free Survival 10%
41. Clinical Stage 10%
42. Pembrolizumab 10%
43. Video-Assisted Thoracoscopic Surgery 10%
44. Esophagogastrostomy 9%
45. Epithelioma 9%
46. Programmed Death 1 Ligand 1 9%
47. Psoas Muscle 9%
48. Thorax Surgery 9%
49. Positron Emission Tomography-Computed Tomography 9%
50. Joint Committee 8%